-
Mashup Score: 0
Patients with axial spondyloarthritis and other related inflammatory diseases demonstrate common microbiome dysfunction characteristics, according to data published in Arthritis & Rheumatology.
Source: www.healio.comCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0FDA approves intravenous formulation of secukinumab - 7 month(s) ago
The FDA has approved an intravenous formulation of Cosentyx for use in patients with psoriatic arthritis, ankylosing spondylitis and nonradiographic axial spondyloarthritis, according to a press release from Novartis.
Source: www.healio.comCategories: Latest Headlines, RheumatologyTweet-
The @US_FDA has approved an intravenous formulation of Cosentyx for use in patients with psoriatic #arthritis, ankylosing spondylitis and nonradiographic axial spondyloarthritis #RheumTwitter https://t.co/Eb9KAx4fAo
-
-
Mashup Score: 0Rheumatoid Arthritis: 5 Things to Know - 7 month(s) ago
Patients’ behaviors and attitudes are integral to proper management, along with recognizing and navigating controversies surrounding treatment. These five things to know will help keep you informed.
Source: www.medscape.comCategories: General Medicine News, Latest HeadlinesTweet-
Here are five things to know about RA #RheumTwitter #RheumatoidArthritis https://t.co/HD7z1bkSdp https://t.co/nsAvDbSkm7
-
-
Mashup Score: 1Rheumatology & Autoimmunity - 7 month(s) ago
Click on the title to browse this journal
Source: onlinelibrary.wiley.comCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
Get the latest work spanning basic, clinical, and translational medical advancements across the full spectrum of #rheumatology and #autoimmunity. Sign up for Rheumatology & Autoimmunity content alerts. đź”” https://t.co/QY90iq8LOy #OpenAccess #RheumTwitter https://t.co/y24XNSOC6J
-
-
Mashup Score: 1
Long-term voclosporin is safe and efficacious for the treatment of lupus nephritis over 3 years, according to data published in Arthritis & Rheumatology.
Source: www.healio.comCategories: Latest Headlines, RheumatologyTweet-
Long-term voclosporin is safe and efficacious for the treatment of #lupus nephritis over 3 years #RheumTwitter #MedTwitter https://t.co/kkYW9YUIYT
-
-
Mashup Score: 2
Retention rates for golimumab treatment at the 5-year mark were consistently high when used as a first-line therapy and did not significantly differ across conditions.
Source: www.hcplive.comCategories: Latest Headlines, RheumatologyTweet-
Retention rates for #golimumab treatment at the 5-year mark were consistently high when used as a first-line therapy and did not significantly differ across conditions. https://t.co/49tuSgqfGe #Rheumatology #RheumTwitter
-
-
Mashup Score: 0
Approximately 220,000 children in the United States were diagnosed with arthritis between 2017 and 2021, with a higher prevalence among those aged 12 to 17 years or living in a food-insecure household, according to data.Non-Hispanic Black or African American children and adolescents, those with anxiety or depression, and those who were physically inactive, overweight or had a heart condition
Source: www.healio.comCategories: Latest Headlines, RheumatologyTweet-
Approximately 220,000 👦 👧children in the United States were diagnosed with #arthritis between 2017 and 2021, with a higher prevalence among those aged 12 to 17 years or living in a food-insecure household #RheumTwitter https://t.co/AtbouSaLwq
-
-
Mashup Score: 1
Patients with new or relapsing granulomatosis with polyangiitis or microscopic polyangiitis should receive rituximab over cyclophosphamide, according to new recommendations from the Pan American League of Associations for Rheumatology.
Source: www.healio.comCategories: Latest Headlines, RheumatologyTweet-
Patients with new or relapsing granulomatosis with polyangiitis or microscopic polyangiitis should receive #rituximab over cyclophosphamide #RheumTwitter https://t.co/PsrsmjCYIM
-
-
Mashup Score: 1Abatacept, certolizumab pegol superior to conventional therapy for rheumatoid arthritis - 7 month(s) ago
Patients with rheumatoid arthritis who receive abatacept or certolizumab pegol achieve clinical remission at higher rates than those receiving active conventional therapy, according to data published in Annals of the Rheumatic Diseases.
Source: www.healio.comCategories: Latest Headlines, RheumatologyTweet-
Patients with rheumatoid #arthritis who receive #abatacept or certolizumab pegol achieve clinical remission at higher rates than those receiving active conventional therapy #RheumTwitter https://t.co/gz3cZNcLSS
-
-
Mashup Score: 0FDA clears third IND for Cabaletta’s CAR T-cell drug; trial will enroll patients with SSc - 7 month(s) ago
The FDA has granted an investigational new drug application for CABA-201, a 4-1BB-containing fully human CD19-CAR T-cell therapy, to be studied in patients with systemic sclerosis, according to a press release from its manufacturer.
Source: www.healio.comCategories: Latest Headlines, RheumatologyTweet-
“We believe CABA-201 has the potential to slow or halt the progression of this autoimmune disease, thereby providing an important treatment option for these patients who currently have very few available treatments.” #RheumTwitter #MedTwitter https://t.co/hGfEbOqsc5
-
Patients with axial spondyloarthritis and other related inflammatory diseases demonstrate common #microbiome dysfunction characteristics #RheumTwitter https://t.co/0xOfVK1CP4